FDA.reportPublic FDA data

cystaran 0.44 % Ophthalmic Solution

RxCUI
1313785
RxNorm name
cystaran 0.44 % Ophthalmic Solution
Display name
cystaran 0.44 % Ophthalmic Solution
Full name
cystaran 0.44 % Ophthalmic Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
b98ee838-ed23-42a9-93b5-72579e490fbacystaran 0.44 % Ophthalmic SolutionPSN23These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 199420250430
b98ee838-ed23-42a9-93b5-72579e490fbaCystaran 0.44 % Ophthalmic SolutionSY23These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 199420250430
b98ee838-ed23-42a9-93b5-72579e490fbaCystaran 4.4 MG/ML (cysteamine hydrochloride 6.5 MG/ML) Ophthalmic SolutionSY23These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 199420250430
b98ee838-ed23-42a9-93b5-72579e490fbaCystaran 4.4 MG/ML Ophthalmic SolutionSY23These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 199420250430
b98ee838-ed23-42a9-93b5-72579e490fbacysteamine 4.4 MG/ML Ophthalmic Solution [Cystaran]SBD23These highlights do not include all the information needed to use CYSTARAN ® safely and effectively. See full prescribing information for CYSTARAN. CYSTARAN (cysteamine ophthalmic solution) 0.44%, for topical ophthalmic use Initial U.S. Approval: 199420250430